Crispr Therapeutics Editas Medicine: Better Buy in 2026?
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Learn various ways to earn money through gig work. Explore strategies to enhance your income through flexible opportunities.
24,561 articlesTwo top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
The Columbia Research Enhanced Real Estate ETF (CRED) yields about 3.6% via pass-through REIT dividends. The fund’s i...
A new Ethereum standard dubbed pERC-20 would hide balances and transfers by default, using zero-knowledge proofs to c...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
The weight loss therapy wave has fireworks at the giants, but smart investors look for underrated weight loss stocks ...
Iran launched drone and missile strikes against Bahrain and Kuwait, raising fears that peace talks could collapse. Ma...
As pay-TV declines, Comcast may lean on first-party data to power targeted streaming ads. This article breaks down ho...
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
A sizable Hershey share sale by the milton hershey school trust sparks questions about insider activity and stock imp...
Alphabet stock moved higher in a week driven by AI chip ambitions, cloud momentum, and a resilient ad business. This ...
Nvidia is reportedly developing a chip platform focused on AI inference workloads amid a shift in the AI landscape. E...
Energy markets rally as Iraq and Kuwait halt crude output, tightening Gulf supply lines amid the Iran conflict. The U...